Global shortage behind distribution shift

Pharmaceutical company defends switch to home delivery service to manage supply shortages of one of its products  Constrained supply of Pegasys (peginterferon alfa-2a) due to “unusual large orders, suspected to be deemed for export” is behind Echo Therapeutics’ decision to change its distribution system for the medication.   In a statement to the AJP, Jude D’Silva